Unlocking New Possibilities with FastPharming

At a Texas stop on Pharma's Almanac's Road to 50 States trans-American tour, iBio CEO Tom Isett and and Advisor Randy Maddux speak with Nigel about the mission and vision of iBio and their FastPharming Expression System.

Tom Isett

Prior to becoming CEO for iBio in March 2020, Mr. Isett played an integral part in reshaping the company's strategy and operations in his role as Board Member and Strategic Advisor since April 2019. He was able to contribute his deep management and strategic insights via the consulting firm he founded in 2015, i.e. Advising, LLC, which supported Fortune 500s, institutional investors, biotechs, and non-profits alike with M&A, turnarounds, and more. Previously, he ran business units for GE, Lonza, and BD, ranging in size from start-up to a half billion in revenues. Notably, he founded BD Advanced Bioprocessing (which sold to Thermo Fisher in 2018) and Commerce Bio, Inc., a cellular immunotherapy company. Mr. Isett received his B.Sc. degree with honors in biological sciences from Drexel University.